The side-effect profiles of anidulafun-gin and its comparator, fluconazole, seem very similar (Table 4). In clinical studies, oral fluconazole canadian was associated with a higher incidence of hepatic ADEs than anidulafungin, although these differences are probably not clinically significant.
Continue reading " Anidulafungin (Eraxis): ADVERSE DRUG REACTIONS "































